Marksans Pharma Ltd.
Snapshot View

52.85 +3.00 ▲6.0%

16 August 2022, 03:31:54 PM
Volume: 3,164,155

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.marksanspharma.com
Market Cap 2,154.40 Cr.
Enterprise Value(EV) 1,722.22 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 4.52 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 11.71 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 28.71 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.84 Calculated using Price: 52.90
Dividend Yield 0.47 Period Ending 2022-03
No. of Shares Subscribed 40.73 Cr. 407,259,847 Shares
FaceValue 1
Company Profile
Marksans Pharma, incorporated in 1992, was a wholly-owned subsidiary of Glenmark Pharmaceuticals. It became a separate entity in March 2003 and the name was changed to Marksans Pharma in 2005.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+6.02%
1 Week
+6.12%
1 Month
+7.42%
3 Month
+12.45%
6 Month
+0.09%
1 Year
-28.82%
2 Year
+7.97%
5 Year
+33.12%
10 Year
+3423.33%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 73.02 45.15 20.45 2.59 7.92 15.88 20.49 31.33 18.72
Return on Capital Employed (%) 38.30 44.64 23.16 3.99 10.60 18.51 25.57 39.76 23.82
Return on Assets (%) 16.52 19.21 11.86 1.54 4.83 10.49 14.17 22.40 13.04

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 86 142 380 454 433 471 542 636 887 1,202
Non Curr. Liab. 10 22 1 -2 16 16 17 24 24 57
Curr. Liab. 297 319 286 259 296 235 233 229 299 356
Minority Int. 7 7 8 8 6 10 10 13 19 21
Equity & Liab. 401 490 676 720 752 731 802 902 1,228 1,636
Non Curr. Assets 157 147 167 280 268 280 271 308 325 435
Curr. Assets 244 343 509 440 484 451 531 594 903 1,201
Misc. Exp. not W/O
Total Assets 401 490 676 720 752 731 802 902 1,228 1,636

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 630 797 893 767 913 1,000 1,134 1,376 1,491 1,576
Other Income 7 12 13 19 8 5 0 7 42 52
Total Income 637 809 906 786 921 1,005 1,135 1,383 1,533 1,628
Total Expenditure -516 -621 -761 -734 -834 -868 -942 -1,037 -1,232 -1,321
PBIDT 121 188 145 52 87 137 193 346 301 307
Interest -19 -16 -10 -7 -10 -10 -9 -8 -8 -9
Depreciation -16 -16 -28 -30 -27 -23 -27 -36 -45 -48
Taxation -13 -44 -24 -4 -14 -24 -36 -64 -61 -65
Exceptional Items
PAT 74 112 83 11 36 80 121 239 187 184
Minority Interest -2 -3 -4 -3 -3 -4 -4 -3 -2 0
Share Associate
Other Related Items
Consolidated Net Profit 72 109 79 9 33 76 117 236 185 184
Adjusted EPS 2 3 2 0 1 2 3 6 5 4

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 39 65 155 31 14 50 27 233 179 99
Cash Fr. Inv. -5 -4 -33 -123 -21 -39 -13 -60 -45 -42
Cash Fr. Finan. -40 -29 17 -58 -3 3 -21 -114 -15 80
Net Change -7 31 138 -150 -10 15 -7 60 118 137
Cash & Cash Eqvt 16 47 185 35 25 40 33 94 212 349

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25
Public 51.75 51.75 51.75 51.75 51.75 51.75 51.75 51.75 51.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 10 Aug 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
Marksans Pharma Limited has informed the Exchange about Schedule of Q1FY23 Earnings Call.
Mon, 08 Aug 2022
Newspaper Advertisements
Marksans Pharma Limited has informed the Exchange about Notice of 30th AGM, Book closure and e-voting information published on August 6, 2022 in the Business Standard (English) and Lakshadeep (Marathi) newspapers
Fri, 05 Aug 2022
Annual General Meeting
Marksans Pharma Limited has informed the Exchange about Notice of Annual General Meeting to be held on 29-Aug-2022

Technical Scans View Details >>

Fri, 12 Aug 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Decrease 1 Year High Decrease 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 914.60 +0.1%
Divi's Laboratories Ltd. 98,918.90 3,732.00 +0.2%
Cipla Ltd. 82,906.37 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 51,917.53 1,573.70 +2.2%
Piramal Enterprises Ltd. 45,855.65 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.32 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.86 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On Marksans Pharma Ltd.

Can I Buy Marksans Pharma Shares now?

What is the Share Price of Marksans Pharma?

What is the Relative Strength Index (RSI) Value of Marksans Pharma?

What is the Market Capital (MCAP) of Marksans Pharma?

What are the key metrics to analyse Marksans Pharma?

What is the Price Performance of Marksans Pharma?